Anyo Labs

📍 Gothenburg, Sweden🗓 Founded 2022👥 16 employees💰 Last funded Jun 2024
Biotechnology Research
LinkedIn
ANYO Labs is focused on virtual screening and de novo small molecular drug generation in early-stage drug discovery projects. The unparalleled computational efficiency of our predictions opens up avenues never explored before allowing for data efficient and cost efficient hit identification. Supporting modules help aid hit-to-lead and lead optimization, while the PPI module can find correlations between hundreds of proteins simultaneously. Get in touch! We are open to discussing your potential projects, collaborations, or discuss any questions you might have.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Anyo Labs?
Anyo Labs has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Anyo Labs last raise funding?
The most recent investment in Anyo Labs recorded on gritt.io was in June 2024.
When was Anyo Labs founded?
Anyo Labs was founded in 2022.
What industry is Anyo Labs in?
Anyo Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Anyo Labs based?
Anyo Labs is headquartered in Gothenburg, Sweden.